These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 13274457)

  • 1. Prostatic enzymes and abnormal bleeding.
    SCOTT EV
    Trans Southeast Sect Am Urol Assoc; 1955; (19th Meeting):50-5; discussion, 56-7. PubMed ID: 13274457
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate.
    TAGNON HJ; SCHULMAN P; WHITMORE WF; LEONE LA
    Am J Med; 1953 Dec; 15(6):875-84. PubMed ID: 13104458
    [No Abstract]   [Full Text] [Related]  

  • 3. THE RELATIONSHIP of abnormal bleeding in surgical patients to administration of dextran, excesses of citrate and to fibrinolysis.
    Surg Forum; 1956; 6():88-121. PubMed ID: 13391424
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinolysis in patients with metastatic carcinoma of the prostate gland.
    DOLAZ EJ; DOLEHIDE RA; FRIEDMAN IA
    Ill Med J; 1955 Mar; 107(3):142-4. PubMed ID: 14353517
    [No Abstract]   [Full Text] [Related]  

  • 5. Metastatic carcinoma of the prostate and bleeding.
    KELLOCK IA; GALLAGHER N
    Br Med J; 1958 Aug; 2(5094):487-9. PubMed ID: 13560910
    [No Abstract]   [Full Text] [Related]  

  • 6. [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. I. SPECIFIC INHIBITORS OF FIBRINOLYSIS].
    NIEWIAROWSKI S
    Pol Arch Med Wewn; 1964; 34():211-7. PubMed ID: 14151493
    [No Abstract]   [Full Text] [Related]  

  • 7. [INHIBITORS OF FIBRINOLYSIS IN THE TREATMENT OF HEMORRHAGE, HEMORRHAGIC DIATHESIS AND SOME OTHER PATHOLOGICAL CONDITIONS. II. INHIBITORS OF PROTEOLYSIS AND FIBRINOLYSIS].
    NIEWIAROWSKI S
    Pol Arch Med Wewn; 1964; 34():351-5. PubMed ID: 14159674
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of fat emulsion intravenously in the control of hemorrhage due to thrombolysin activity.
    BIGGS AW; DOUGDALE M; RAINES SL; NEFT LG
    South Med J; 1961 Nov; 54():1252-4. PubMed ID: 13869122
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrinogenopenia and excessive fibrinolysins in the blood: a cause of severe post-partum haemorrhage.
    BYRNE AD
    Med J Aust; 1956 Mar; 43(11):455-9. PubMed ID: 13308587
    [No Abstract]   [Full Text] [Related]  

  • 10. HAEMORRHAGE AND FIBRINOLYSIS.
    FLUTE PT
    Proc R Soc Med; 1964 Jul; 57(7):603-6. PubMed ID: 14178952
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogenopenia, bleeding and intravascular coagulation in cancer of the prostate. Report of a case.
    Andersson L; Kjellstrand CM; Saldeen T; Forkman A
    Acta Chir Scand; 1966 Oct; 132(4):466-75. PubMed ID: 5298247
    [No Abstract]   [Full Text] [Related]  

  • 12. Circulating fibrinolysin in a case of prostatic carcinoma with bony metastases.
    BERGEN S; SCHILLING FJ
    Ann Intern Med; 1958 Feb; 48(2):389-98. PubMed ID: 13509544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypofibrinogenemia and fibrinolysis in metastatic cancer of the prostate as a rare cause of unilateral renal hemorrhage].
    STEFAN H; CHROBAK L; GROH J
    Cas Lek Cesk; 1960 Mar; 99():302-6. PubMed ID: 13833992
    [No Abstract]   [Full Text] [Related]  

  • 14. A modified screening test to detect potential bleeders.
    Rifkin A; Reid WO
    Am J Med Technol; 1966; 32(6):393-4. PubMed ID: 4227288
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostatic enzymes and abnormal bleeding.
    SCOTT EV
    J Urol; 1956 Jan; 75(1):116-21. PubMed ID: 13286807
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some unusual aspects of fibrinolysis in the diagnosis of prostatic carcinoma].
    MAIRANO C; RIGOTTI E
    Minerva Urol; 1960; 12():148-51. PubMed ID: 13765499
    [No Abstract]   [Full Text] [Related]  

  • 17. [A syndrome of hematological changes in cancer of the prostate gland].
    Rupniewska ZM; Czarkowska D; Miturzyńska-Stryjecka H
    Pol Tyg Lek; 1969 Dec; 24(48):1858-9. PubMed ID: 5212521
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal plasma proteolytic activity; diagnosis and treatment.
    SCOTT EV; MATTHEWS WF; BUTTERWORTH CE; FROMMEYER WB
    Surg Gynecol Obstet; 1954 Dec; 99(6):679-88. PubMed ID: 13216514
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolysis and fibrinolytic hemorrhagic diatheses].
    FAVRE-GILLY J; POTTON F
    J Med Lyon; 1952 Oct; 33(786):869-81. PubMed ID: 13023221
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metastatic prostatic cancer with hemorrhagic diathesis due to fibrinolysis; case report].
    RASMUSSEN J; SCHWARTZ M
    Ugeskr Laeger; 1957 Aug; 119(34):1086-90. PubMed ID: 13468146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.